Skip to main content
National Cancer Institute U.S. National Institutes of Healthwww.cancer.gov
 Surveillance Epidemiology and End Results
providing information on cancer statistics to help reduce the burden of this disease on the U.S. population
 SEER Home
 SEER Home Finding Statistics Cancer Registrars Statistical Resources Publications About SEER  

Revision History of the SEER Cancer Statistics Review, 1975-2005

The files on this page are provided in Portable Document Format (PDF).

Date Revision Affected Pages
6/26/2008 The CSR Introduction was updated to explain the increase from a maximum of 3 joinpoints per regression line analysis to 4 joinpoints per regression line analysis. Introduction

The CSR Introduction appears in the topic:

6/26/2008 The tables that show Joinpoint regression line analysis results when up to 4 Joinpoints are allowed were collected to create Section 34 of the CSR. The tables within Section 34 are still included in their appropriate cancer site sections. Section 34: Trends with up to 4 Joinpoints
6/20/2008 Additional tables were added that show Joinpoint regression line analysis results when up to 4 Joinpoints are allowed. The graphs that show Joinpoint trends lines were updated to be based on Joinpoint analyses with a maximum of 4 Joinpoints. The Joinpoint analyses previously used in the CSR allowed a maximum of 3 Joinpoints. Tables and Graphs that show Joinpoint results in Sections 1 through 28 and Section 33.
5/30/2008 The Adolescent and Young Adult Cancer chapter was released. Section 32: Adolescent and Young Adult Cancer
5/2/2008 There was a typo In the last paragraph on the first page of the Veterans Affairs Adjustment chapter. The overall cancer burden for females was underestimated by 0.05%, not 0.5%. Section 33: Veterans Affairs Adjustment
4/17/2008 Incorrect rates were displayed in the tables titled SEER INCIDENCE AND U.S. DEATH RATES, AGE-ADJUSTED AND AGE-SPECIFIC RATES, BY RACE.
  • The mortality estimates age-adjusted to the world standard were incorrect in each of the CSR sections from Section 2 through Section 27.
  • Incorrect estimates were displayed for gender specific cancer sites including : in situ breast, cervix uteri, corpus & uterus, ovary, prostate and testis.
Tables changed:
2-4, 3-4, 4-9, 5-4, 6-7, 6-8, 7-4, 8-4, 9-4, 11-4, 12-4, 13-8, 14-4, 15-7, 15-8, 16-4, 18-4, 19-4, 20-4A, 21-4, 22-4, 23-4, 24-4, 25-4, 26-4, 27-4

Tables appear in the each section from Section 2 through Section 27.

 
National Cancer Institute    National Cancer Institute    Department of Health and Human Services     National Institutes of Health    USA.gov